Description

2-Day Intensive Revision Course – FRCOphth Part 2 Written

An intensive final revision program designed for candidates preparing for the July 2026 FRCOphth Part 2 Written exam.

This 2-day course focuses on high-yield concepts, visual recalls, commonly tested MCQ themes, and practical exam strategy to help candidates revise efficiently during the final stretch before the exam.

The sessions are structured around the topics and question styles that candidates repeatedly find challenging in the real exam, with emphasis on rapid interpretation, concept integration, and avoiding common pitfalls.

Live Class Dates

📅 27th June 2026
📅 28th June 2026

Course Format

• 2-Day Intensive Live Revision
• 5+ hour live class each day
• Interactive discussion-based format
• Integrated MCQ discussion throughout the sessions
• High-yield visual and conceptual recalls
• 30 days of recording access after the course
• 30 days of course access from the date of purchase

Key Areas Covered

• Retina
• Neuro-ophthalmology
• Optics & Refraction
• Statistics & Evidence-Based Medicine
• Glaucoma
• High-yield recalls and “most missed” concepts
• Rapid visual diagnosis and interpretation
• Exam strategy and final consolidation
• And much more

Who Is This For?

• July 2026 FRCOphth Part 2 Written candidates
• Re-sitters seeking focused revision
• Busy clinicians needing efficient high-yield preparation
• Candidates struggling with MCQ interpretation and recall-heavy topics

Why Candidates Choose This Course

The final weeks before the exam should focus on consolidation, recall, and exam technique — not endless passive reading.

This course is designed to help candidates:

• Prioritise high-yield revision
• Strengthen exam-focused thinking
• Improve recall speed and accuracy
• Avoid common MCQ traps
• Build confidence before exam day

Early Bird Offer — Valid Till June 7th Only

Register before June 7th and receive FREE access to our brand new 800+ FRCOphth QBank featuring curated questions based on Oxford, Kanski, and OST resources.